Patents by Inventor Ambarish Umakant SHAH

Ambarish Umakant SHAH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS OF MONOCLONAL ANTIBODIES
    Publication number: 20220204597
    Abstract: The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
    Type: Application
    Filed: November 19, 2021
    Publication date: June 30, 2022
    Applicant: MEDIMMUNE LIMITED
    Inventors: Brian LOBO, Deborah Sweet GOLDBERG, Monika Sood SHARMA, Ambarish Umakant SHAH
  • FORMULATIONS OF MONOCLONAL ANTIBODIES
    Publication number: 20220089713
    Abstract: The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
    Type: Application
    Filed: April 7, 2021
    Publication date: March 24, 2022
    Inventors: Brian Lobo, Deborah Sweet Goldberg, Monika Sood Sharma, Ambarish Umakant Shah
  • FORMULATIONS OF MONOCLONAL ANTIBODIES
    Publication number: 20200283516
    Abstract: The present invention provides a formulation comprising: (i) a monoclonal antibody; and (ii) an ionic excipient; wherein the monoclonal antibody is present at a concentration of about 50 mg/ml or greater (e.g. about 50 mg/ml to about 200 mg/ml) and the ionic excipient is present at a concentration of about 50 to about 150 mM and the formulation has a pH of 5.5 to 6.5.
    Type: Application
    Filed: February 28, 2018
    Publication date: September 10, 2020
    Applicant: MEDIMMUNE LIMITED
    Inventors: Brian LOBO, Deborah Sweet GOLDBERG, Monika Sood SHARMA, Ambarish Umakant SHAH